Fluoptics
Fluoptics SAS is a Grenoble-based medical device subsidiary of Getinge that designs NIR fluorescence imaging systems (FLUOBEAM LX Red and FLUOBEAM LM) for thyroid/parathyroid and plastic/reconstructive surgery, distributed globally through Getinge's enterprise sales network.
- Company typePrivate
- Founded2009
- HeadquartersGrenoble, France
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Fluoptics does
Fluoptics SAS is a French medical device company headquartered in Grenoble, France, founded in 2009 and operating as a wholly-owned subsidiary of Getinge AB (Stockholm). The company designs and manufactures fluorescence-based surgical imaging systems, with a portfolio of two dedicated devices: the FLUOBEAM LX Red, which combines autofluorescence and fluorescence perfusion imaging for thyroid and parathyroid surgery, and the FLUOBEAM LM, which uses Indocyanine Green (ICG) fluorescence to provide real-time tissue perfusion imaging in plastic and reconstructive surgery. Both systems employ Class 1 laser technology with high-sensitivity detectors designed to operate under ambient operating-room lighting, and feature an ergonomic joystick interface enabling surgeon-controlled operation from the sterile field.
The underlying technology is near-infrared (NIR) fluorescence and autofluorescence imaging, positioning Fluoptics within a global NIR imaging market valued at USD 2.19B in 2024 and projected to reach USD 2.96B by 2033. The company serves two primary surgical specialties: thyroid and parathyroid surgeons requiring real-time parathyroid gland identification and perfusion visualization, and plastic and reconstructive surgeons needing intraoperative assessment of tissue perfusion and flap viability. Products have been developed and clinically validated by international clinical teams.
Fluoptics generates revenue through capital equipment sales of its FLUOBEAM product line, with pricing not publicly disclosed and US sale restricted to physicians under federal law. Distribution is conducted globally through Getinge's enterprise sales and distribution network, covering EMEA, the Americas, Asia, and Oceania, which is the primary go-to-market channel. The company is listed among key players in the NIR imaging market alongside larger medtech firms including Stryker, KARL STORZ, Olympus, Medtronic, Hamamatsu Photonics, PerkinElmer, and Carl Zeiss Meditec. Headcount is reported at 11–50 employees, consistent with a focused niche medical device operation operating within a much larger parent organization's commercial infrastructure.
Fluoptics firmographics
Firmographics- Name
- Fluoptics
- Legal name
- FLUOPTICS SAS
- Website
- https://fluoptics.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Fluoptics SAS is a Grenoble-based medical device subsidiary of Getinge that designs NIR fluorescence imaging systems (FLUOBEAM LX Red and FLUOBEAM LM) for thyroid/parathyroid and plastic/reconstructive surgery, distributed globally through Getinge's enterprise sales network.
- Ownership category
- akta.pro rank
Fluoptics industry classification
Industry- Product category
- Surgical Fluorescence Imaging Equipment
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH)
- akta.pro secondary industry
- Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)
Keywords
Where Fluoptics is headquartered
LocationHeadquarters
- HQ city
- Grenoble
- HQ country
- France
- HQ region
- Europe
Markets served
Fluoptics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Distribution channels1 record
Marketing channels1 record
Fluoptics product offering
Product offeringCore offering
Fluoptics develops and manufactures fluorescence imaging systems that help surgeons visualize parathyroid gland location and tissue perfusion in real time during operations. Its product family comprises the FLUOBEAM LX Red, a dual-mode autofluorescence and fluorescence perfusion device for thyroid and parathyroid surgery, and the FLUOBEAM LM, an ICG fluorescence imaging system for plastic and reconstructive surgery. Devices are sold to healthcare professionals through Getinge's global distribution network.
Product overview
Fluoptics is a medical imaging company that offers a portfolio of fluorescence imaging devices designed for surgical applications. The product line consists of two dedicated devices: FLUOBEAM LX Red (for thyroid and parathyroid surgery) and FLUOBEAM LM (for plastic and reconstructive surgery). Both products leverage autofluorescence and fluorescence perfusion imaging technologies to provide surgeons with real-time visualization of tissue and anatomical structures during surgery, enabling greater precision, efficiency, and safety.
Differentiator
Problem solved
Functional benefit
Brands
- FLUOBEAM LX Red: An imaging device exclusively dedicated to thyroid and parathyroid surgery, combining autofluorescence and fluorescence perfusion imaging.
- FLUOBEAM LM
Products and services
- FLUOBEAM LX Red Dedicated imaging device for thyroid and parathyroid surgery that combines autofluorescence and fluorescence perfusion imaging to provide surgeons with unprecedented understanding of parathyroid gland location and tissue perfusion in real time. Intended for surgical specialists and hospitals performing thyroid and parathyroid procedures.
- FLUOBEAM LM Innovative surgical imaging solution using Indocyanine Green (ICG) with integrated fluorescence imaging to provide surgeons with a real-time image of tissue fluorescence in the operative field for perfusion assessment in plastic and reconstructive surgery. Intended for plastic and reconstructive surgeons and associated hospital surgical departments.
Companies that use Fluoptics
Customer profileSegments2 records
Ideal customer profiles2 records
Fluoptics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Fluoptics partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights4 records
Fluoptics competitors and assessment
Company assessmentDirect peers
- Stryker: Major surgical imaging player through its SPY-PHI fluorescence imaging platform for perfusion assessment across plastic, reconstructive and general surgery — directly competes with Fluoptics' FLUOBEAM LM.
- KARL STORZ: Endoscopy and surgical imaging company with NIR/ICG fluorescence imaging systems (e.g., IMAGE1 S Rubina) used in laparoscopic and open surgical workflows — overlaps with Fluoptics' intraoperative fluorescence use cases.
- Olympus: Endoscopic and surgical visualization company offering NIR fluorescence imaging modes integrated into its VISERA and ENDO-AID platforms for general and specialty surgery — direct competitor in NIR surgical imaging.
- Quest Medical Imaging: Specialized fluorescence imaging manufacturer developing multi-wavelength NIR systems for open and minimally invasive surgery — directly competes with Fluoptics as a focused fluorescence imaging peer.
Broad incumbents
- Medtronic: Diversified medical technology leader with surgical products and fluorescence imaging integration in laparoscopic and robotic-assisted platforms — competes broadly with Fluoptics across multiple surgical specialties.
- Carl Zeiss Meditec: Ophthalmic and surgical microscopy leader with intraoperative fluorescence visualization in neurosurgical and ophthalmic microscope platforms — adjacent competition for fluorescence-based surgical visualization.
- Intuitive Surgical: Robotic surgical system (da Vinci) provider that integrates Firefly NIR fluorescence imaging — broad incumbent in surgical visualization with overlapping intraoperative imaging use cases.
- Leica Microsystems (Danaher): Surgical microscopy and imaging brand under Danaher, offering fluorescence modules for neurosurgical, ENT and ophthalmic OR workflows — adjacent surgical fluorescence visualization competitor.
Others
- Hamamatsu Photonics: Photonics components and imaging modules supplier whose detectors and light sources underpin many fluorescence imaging systems — enabling technology provider to the NIR surgical imaging ecosystem that Fluoptics participates in.
- PerkinElmer: Life sciences and imaging instrumentation company with NIR detection technologies used in research and certain surgical/preclinical imaging applications — enabling/imaging technology participant in the broader NIR imaging market.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Fluoptics social profiles
Digital presenceFluoptics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fluoptics leadership team
Management profileNumber of profiles
Fluoptics funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fluoptics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fluoptics
What does Fluoptics do?
Fluoptics develops and manufactures fluorescence imaging systems that help surgeons visualize parathyroid gland location and tissue perfusion in real time during operations. Its product family comprises the FLUOBEAM LX Red, a dual-mode autofluorescence and fluorescence perfusion device for thyroid and parathyroid surgery, and the FLUOBEAM LM, an ICG fluorescence imaging system for plastic and reconstructive surgery. Devices are sold to healthcare professionals through Getinge's global distribution network.
Is Fluoptics a public or private company?
Fluoptics is a private company. It is classified as corporate owned and is currently operating.
When was Fluoptics founded?
Fluoptics was founded in 2009. It employs 11 to 50 people.
Where is Fluoptics based?
Fluoptics is headquartered in Grenoble, France, in the Europe region.
Who are Fluoptics's main competitors?
Direct peers on record are Stryker, KARL STORZ, Olympus and Quest Medical Imaging. Broad incumbents are Medtronic, Carl Zeiss Meditec, Intuitive Surgical and Leica Microsystems (Danaher). Others are Hamamatsu Photonics and PerkinElmer.
Does Fluoptics have an API?
No public API is recorded for Fluoptics.
What industry is Fluoptics in?
Fluoptics's product category is Surgical Fluorescence Imaging Equipment. Its primary akta.pro industry code is HLAHADAH, Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence), with a secondary code of HLAHABAG, Interventional Radiology & Image-Guided Therapy Systems. Its NAICS code is 339112 and its SIC code is 3841.